These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34842366)
1. Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers. Duflot T; Pereira T; Tavolacci MP; Joannidès R; Aubrun F; Lamoureux F; Lvovschi VE CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):82-93. PubMed ID: 34842366 [TBL] [Abstract][Full Text] [Related]
2. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468 [TBL] [Abstract][Full Text] [Related]
5. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers. Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain. De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069 [TBL] [Abstract][Full Text] [Related]
9. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide. de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797 [TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of the activity of the morphine glucuronides. Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027 [TBL] [Abstract][Full Text] [Related]
11. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers. Murthy BR; Pollack GM; Brouwer KL J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351 [TBL] [Abstract][Full Text] [Related]
12. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories. Du X; Skopp G; Aderjan R Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients. Ihmsen H; Schüttler J; Jeleazcov C Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559 [TBL] [Abstract][Full Text] [Related]
14. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose. Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480 [TBL] [Abstract][Full Text] [Related]
16. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Hasselström J; Säwe J Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060 [TBL] [Abstract][Full Text] [Related]
17. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat. Van Crugten JT; Somogyi AA; Nation RL; Reynolds G Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481 [TBL] [Abstract][Full Text] [Related]
18. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Wolff T; Samuelsson H; Hedner T Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig. Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Quigley C; Joel S; Patel N; Baksh A; Slevin M Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]